Authors


Prof. Norbert Körber

Latest:

A new treatment paradigm with ab-interno canaloplasty for POAG

With minimally invasive surgery procedures becoming increasingly popular in glaucoma management, canaloplasty using an ab-interno surgical technique offers enhanced natural aqueous outflow in open-angle glaucoma.


Dr Laurent Bataille

Latest:

The relationship between myopia and conjunctival-scleral geometry

A recent prospective study analysed the relationship between corneo-scleral geometry and the axial length of the eye to develop preliminary prediction models of the axial length of the eye based on clinical data.


Laxmi V. Devisetty, MD; and Thiran Jayasundera, MD, MS, FACS, FRCSC, FANZCO

Latest:

Inherited retinal diseases and gene therapies: A pharmaceutical overview

For retinal specialists grappling with diseases once thought “untreatable,” gene therapies present a wide range of viable options




Dr Vasant Raman

Latest:

The rationale for enabling nurses to inject dexamethasone implants

Nurses and other allied healthcare professionals can safely and effectively deliver intravitreal steroid implants in a clean room setting, which has reduced patient waiting times.


Prof. Taiji Sakamoto

Latest:

Assessing the quality of real-world evidence in retinal diseases

A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.


Dr J. Fernando Arevalo

Latest:

Using swept-source OCT and OCT angiography to image choroidal tumours

SS-OCT provides a clear view of the eye’s internal structures and any abnormalities, helping to differentiate benign from malignant lesions.



Dr Redmer van Leeuwen

Latest:

Ophthalmology and the climate crisis: Time to take responsibility

The healthcare sector has high greenhouse gas emissions, to which ophthalmology is a significant contributor. Reducing waste, reusing instruments and medication and increasing our use of telemedicine can all contribute to reducing the carbon footprint of our specialty.


Marlisa Miller, Editorial Intern

Latest:

ESCRS 2023: Presbyopia treatment with microporation therapeutic technology by Ace Vision Group

AnnMarie Hipsley, DPT, PhD, met with Ophthalmology Times Europe to discuss Ace Vision Group's microporation therapeutic technology, used to treat presbyopia.


Prof. Brendan James Vote

Latest:

Small-aperture IOL yields high satisfaction in retrospective review

The IC-8 IOL uses the small-aperture concept to extend cataract patients’ depth of focus. Patients report high approval and reduced spectacle dependence.


Lynda Charters; Reviewed by Dr Richard W Hertle

Latest:

It takes a village to beat visual system diseases in children

Community support is the most important factor in ascertaining effective treatments for paediatric eye diseases.



Dr Akihiro Kakehashi

Latest:

The truth about invisible posterior vitreous structures

Understanding vitreomacular interface diseases is key to treatment.


By Lynda Charters; Reviewed by Lotfi Merabet, OD, PhD

Latest:

Cerebral visual impairment: Documenting visual effects and simplifying visual life

With investigations into CVI in the early phases, collaboration across the Atlantic is crucial



Dr Jorge Fortun

Latest:

Real-world experience of OCT-A for retinal diagnoses and management

As OCT-A devices become faster, the algorithms advance and the instrument costs decrease, more widespread utilisation in retina practices is likely.


Mariya Moosajee, MBBS, BSc, PhD, FRCOphth

Latest:

Optimizing Care For Patients With Retinal Disorders

Key takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.


Dr Samantha Rosen

Latest:

The complicated ins and outs of paediatric glaucoma

Early detection and diagnosis are key for these young patients



Lucio Buratto
Lucio Buratto

Latest:

New IOL offers patients greater spectacle independence over wider range

Patients desire spectacle independence at all distances. Early experience with a recently launched IOL suggests that it can satisfy their demands for extended depth of vision.


Dr Gordana Sunaric Mégevand

Latest:

Personalising glaucoma surgery: The role of MIGS

Minimally invasive glaucoma surgery (MIGS) is appealing to glaucoma patients and surgeons; however, it should not be adopted without further high-quality research and careful reporting. Selection of the appropriate treatment for individual patients must be evidence based.



Prof. Sathish Srinivasan

Latest:

A simple solution for complex corneas

Corneal aberrations may occur more frequently than is generally appreciated, and they affect the visual outcomes following cataract surgery. Small-aperture optics provide a solution for a large category of patients who are otherwise not well served by complex IOLs.


Cheryl Guttman Krader; Reviewed by Dr David F. Chang

Latest:

Expert on floppy iris syndrome offers practical pearls for success

Strategies for the management and prevention of floppy iris syndrome include intraoperative interventions and recommendations on alternatives to tamsulosin for medical therapy in men with cataracts.


Lynda Charters; Reviewed by Dr Ramin Khoramnia

Latest:

IRISS registry study offers real-world outcomes

Investigators found that a fluocinolone acetonide implant maintained good real-world vision levels in patients with diabetic macular oedema who had good baseline vision.


Sally Tucker

Latest:

ESCRS 2023: OWL brings more of the 'world' to Ophthalmic World Leaders

OWL's ESCRS 2023 event on Sunday, September 10, at 7 pm, promises an evening of visionary leadership and collaboration in ophthalmic innovation.


Dr David A. Eichenbaum

Latest:

Repeatable, high-quality imaging leads to better diabetic eye disease management

SD-OCT is providing reproducible, high-quality, registered images to assess the treatment response in macular disease.


© 2024 MJH Life Sciences

All rights reserved.